Many studies have discussed the vasoprotective role of NO generated by endothelial nitric oxide synthase (eNOS) in NAFLD; however, NO activity carries advantages as well as disadvantages. The gene discussed is NOS3; the disease is metabolic dysfunction-associated steatotic liver disease.